Novel Therapeutic Strategies for Gynecological Cancer: Molecular Biological Insights

Dear Colleagues,

Gynecological cancers, including those of the ovaries, cervix, uterus, fallopian tubes, and vulva, pose significant challenges in clinical management and treatment. Despite advances in traditional therapies such as surgery, chemotherapy, and radiation, the recurrence rates and mortality associated with these cancers remain substantial. In recent years, there has been a growing interest in exploring novel therapeutic strategies that target molecular pathways involved in the development and progression of gynecological malignancies. These approaches offer promising avenues for more effective and personalized treatment options. Here, we delve into some of the key molecular biological insights driving these novel therapeutic strategies.

Molecular biological insights have paved the way for the development of novel therapeutic strategies that promise to transform the landscape of gynecological cancer treatment. Targeted therapies, immunotherapy, epigenetic modulators, and personalized medicine approaches offer new hope for improving patient outcomes and advancing towards the goal of precision oncology in the management of gynecological malignancies.

The present Special Issue, entitled “Novel Therapeutic Strategies for Gynecological Cancer: Molecular Biological Insights”, aims to present recent research developments to the wider community involved in this field. We welcome contributions in this field.

Dr. Jiantai Timothy Qiu
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• gynecological cancers
• cervical cancer
• uterine cancer
• ovarian cancer
• fallopian tube cancer
• peritoneal cancer and vulvar cancer
• targeted therapy
• immunotherapy
• epigenetic modulator
• cancer vaccines and cell therapy
• molecular profiling and personalized medicine